Adverse reactions to propranolol in hospitalized medical patients: A report from the Boston Collaborative Drug Surveillance Program

scientific article published on 01 October 1973

Adverse reactions to propranolol in hospitalized medical patients: A report from the Boston Collaborative Drug Surveillance Program is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0002-8703(73)90139-7
P953full work available at URLhttps://api.elsevier.com/content/article/PII:0002870373901397?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:0002870373901397?httpAccept=text/plain
P698PubMed publication ID4728124

P50authorDavid J. GreenblattQ88911712
P2093author name stringJ. Koch-Weser
P2860cites workPropranolol-induced depressionQ28365619
Comprehensive Drug SurveillanceQ30241219
A NEW ADRENERGIC BETARECEPTOR ANTAGONISTQ33971458
Computer analysis of epidemiologic data on effect of drugs on hospital patientsQ36074990
Perspectives in adrenergic beta-receptor blockadeQ39982386
Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applicationsQ40039750
The treatment of shock with beta adrenergic blockadeQ43528426
Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applicationsQ44729426
Effect of Age and Sex on Human Drug MetabolismQ50348052
The effect of propranolol on anxiety.Q51346924
Unwanted effects of propranolol.Q54222395
The treatment of migraine with propranololQ54427936
DRUG SURVEILLANCE UTILISING NURSE MONITORS An Epidemiological ApproachQ57946623
Beta adrenergic blockade in the circulatory regulation of hyperkinetic statesQ68751439
Propranolol in hypertension: a study of long-term therapy, 1964-1970Q70437062
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectCardiology and cardiovascular medicineQ96320350
P304page(s)478-484
P577publication date1973-10-01
P1433published inAmerican Heart JournalQ2227156
P1476titleAdverse reactions to propranolol in hospitalized medical patients: a report from the Boston Collaborative Drug Surveillance Program
Adverse reactions to propranolol in hospitalized medical patients: A report from the Boston Collaborative Drug Surveillance Program
P478volume86

Reverse relations

cites work (P2860)
Q34515782A comparative trial of clonidine, propranolol and placebo in the treatment of moderate hypertension
Q40085968Adverse effects of antianxiety drugs
Q67275834Adverse effects of antiarrhythmic drugs
Q40311396Adverse effects of antihypertensive drugs
Q39874234Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program
Q28330850Adverse reactions to practolol in hospitalized patients: a report from the Boston Collaborative Drug Surveillance Program
Q39103748Alpha- and Beta-Adrenergic Receptor Blocking Agents Combined with a Diuretic in the Treatment of Essential Hypertension
Q43944377An approach to the treatment of essential hypertension
Q51868908Anaesthetic problems associated with the treatment of cardiovascular disease: II. beta-adrenergic antagonists
Q72512060Angiodysplasia
Q72542990Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease
Q72540066Anxiety and depression in patient on nadolol
Q40090423Beta-adrenergic blockade and the gastrointestinal system
Q36465582Beta-adrenergic function in aging. Basic mechanisms and clinical implications
Q67516362Beta-adrenergic receptor blockade and renal function
Q34246704Beta-blocking drugs and anxiety
Q39793128Blood Levels of Drugs Used in the Treatment of Cardiac Arrhythmias
Q66922477Brady-Tachy Syndrome with Prolonged Retrograde Conduction due to Digitalis and Propranolol Intoxication
Q38160762Clinical Pharmacology of Antihypertensive Drugs in Children
Q72570518Clinical experiences in arterial hypertension in the elderly
Q42247574Clinical responses to oxprenolol in the elderly
Q42274072Complete atrioventricular block associated with propranolol therapy
Q44080790Delta infection without increase in severity of hepatitis
Q67007351Detection of drug-induced disease
Q72430108Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents
Q34110511Drug prescribing for the elderly.
Q39774063Drug use in the elderly: a review of problems and special considerations
Q37105405Drug-Induced Cardiovascular Diseases
Q69567038Effect of propranolol on indices of intermittent myocardial ischemia, assessed by exercise testing and ambulatory ST-segment monitoring
Q67490056Effects of oxprenolol on the airways of normal and bronchitic subjects
Q39105831Efficacy of cardioselective beta adrenergic blockade with intravenously administered tolamolol in the treatment of cardiac arrhythmias
Q39155283Evidence for Improved Cardiac Performance after Beta-Blockade in Patients with Coronary Artery Disease
Q35000479Geriatric pharmacology
Q36999217High dose propranolol in the treatment of angina pectoris: relationship of dose to blood levels and hemodynamic consequences
Q83358999Hypertension in the elderly
Q93857498Hypertension in the elderly
Q67592437Intravenous atenolol in elderly patients in the early phase of acute myocardial infarction
Q72484754Long-term course of arterial hypertension treated with beta-blockers. 1. Comparison with the results obtained with non-beta-blocking antihypertensive agents
Q34063156Pharmacologic therapy of ventricular arrhythmias
Q37149283Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes
Q69871419Polymorphic metabolism of the beta-adrenoreceptor blocking drugs and its clinical relevance
Q46123053Propranolol toxicity presenting with early repolarization, ST segment elevation, and peaked T waves on the ECG.
Q67312007Propranolol-induced Urticaria: Successful Therapy with Tolamolol
Q34248581Psychopharmacologic issues in the diagnosis and treatment of organic mental disorders.
Q66942615Psychosis: A Probable Result of Propranolol Therapy
Q33880949Relationship between polymorphisms in beta -2 adrenergic receptor gene and ischemic stroke in North Indian Population: a hospital based case control study
Q36489562Required beta blocker profile in the elderly
Q38749920Safety and effectiveness of propranolol in severely burned patients: systematic review and meta-analysis
Q36927124Side effects and contraindications of beta-receptor blocking agents
Q70336545Simplified antihypertensive therapy with pindolol retard
Q36716830Surgical treatment of hypertrophic obstructive cardiomyopathy in the elderly
Q72030112Systolic functional response of normal older and younger adult left ventricles to beta-blockade during exercise
Q57797740The Safety and Efficacy of Propranolol in Reducing the Hypermetabolic Response in the Pediatric Burn Population
Q34517399The effect of ageing on the hepatic clearance of propranolol
Q34448943The influence of age, smoking and hyperthyroidism on plasma propranolol steady state concentration
Q67314644The relationship of paroxysmal ventricular tachycardia complicating the acute phase and ventricular arrhythmia during the late hospital phase of myocardial infarction to long-term survival
Q40327652Therapeutic drug monitoring of antiarrhythmic agents
Q34516492beta-Adrenoceptor-blocking agents and the kidney: effect of nadolol and propranolol on the renal circulation

Search more.